ProQR Therapeutics Provides Update on Ophthalmic Assets Press release … our primary focus at ProQR remains on our Axiomer ® RNA editing platform,” said Daniel A. de Boer, Founder and … September 27, 2023
ProQR Announces Planned Changes to Board Composition Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Februar 09, 2026
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day Press release … Further validate and expand ProQR's proprietary Axiomer ® RNA editing platform through first development candidate … Januar 29, 2019
ProQR Announces Results for the Second Quarter of 2017 Press release … In May, three abstracts were presented on three of ProQR’s RNA editing approaches for inherited blindness at the Annual … August 16, 2017